Immunotherapy Targeting Triple-Negative Breast Cancer using NY-ESO-1-Specific TCRs and blockade of immune suppression

Project: State

Project Details

StatusFinished
Effective start/end date12/1/14 → 11/30/18

Funding

  • Cancer Prevention and Res Inst of Texas: $2,172,341.18